InhibOx CEO explains to IPT why cloud computing will revolutionise Drug Discovery
InhibOx CEO Paul Davie talks to Innovations in Pharmaceutical Technology about how cloud computing is set to transform drug discovery.
Download the full article here, or visit the IPT online website to view the June edition of the journal.